Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mesa LaboratoriesMLAB -0.05%75 Days Sales Outstanding is 59.56 as of Jun. 2026, which is 3% below its 10-year median of 61.29. GuruFocus rates MLAB with a GF Score™ of 75/100 and a GF Value™ of $106.26 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 2,464 Hardware companies, Mesa Laboratories ranks better than 67.78% on this metric.
Mesa Laboratories (NAS:MLAB) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Mesa Laboratories Days Sales Outstanding Related Terms
Mesa Laboratories Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Mesa Laboratories's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MLAB vs AERG, USBC, WRAP: Days Sales Outstanding Comparison
For the Scientific & Technical Instruments subindustry, Mesa Laboratories's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mesa Laboratories Days Sales Outstanding vs Hardware Industry
For the Hardware industry and Technology sector, Mesa Laboratories's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Mesa Laboratories's Days Sales Outstanding falls into.
Mesa Laboratories Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mesa Laboratories (MLAB) has a Days Sales Outstanding of 59.56 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Mesa Laboratories and its competitors. This is near median its historical median of 61.29. Over the past decade, Mesa Laboratories' Days Sales Outstanding has ranged from 47.46 to 69.79. According to the industry distribution chart, Mesa Laboratories ranks #794 out of 2464 companies in the Hardware industry, placing it in the top 32.2%.
Is Mesa Laboratories' Days Sales Outstanding too high?
Mesa Laboratories' current Days Sales Outstanding of 59.56 is near median its 10-year median of 61.29. Over the past 10 years, this metric has ranged from a low of 47.46 to a high of 69.79. The Hardware industry median Days Sales Outstanding is 73.33. Mesa Laboratories' value of 59.56 is 18.8% below this industry median. Based on the distribution chart, Mesa Laboratories ranks #794 out of 2464 companies in the Hardware industry, which is above the industry midpoint. Overall, Mesa Laboratories has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mesa Laboratories' Days Sales Outstanding compare to AERG and USBC?
According to the Hardware industry distribution chart, Mesa Laboratories ranks #794 out of 2464 companies for Days Sales Outstanding. This puts Mesa Laboratories in the upper half of its industry. The industry median Days Sales Outstanding is 73.33. Mesa Laboratories' value of 59.56 is 18.8% below this benchmark. Historically, Mesa Laboratories' own Days Sales Outstanding has ranged from 47.46 to 69.79 over the past decade. While the company's 10-year median is 61.29 vs. the industry median of 73.33, Mesa Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Hardware company?
The median Days Sales Outstanding among Hardware companies is 73.33, based on 2,464 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mesa Laboratories's current Days Sales Outstanding of 59.56 is 18.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Mesa Laboratories and its competitors. For the Hardware industry, the median Days Sales Outstanding is 73.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mesa Laboratories's current Days Sales Outstanding is 59.56, which is near median its own 10-year median of 61.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Mesa Laboratories (MLAB) is currently considered Modestly Overvalued. The stock's GF Value™ is $106.26, compared to a current price of $124.33 — trading 17% above its estimated fair value. The current Days Sales Outstanding is 59.56, which is near median its 10-year median of 61.29 and 18.8% below the Hardware industry median of 73.33. Mesa Laboratories' overall GF Score™ is 75/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Mesa Laboratories (MLAB), the current Days Sales Outstanding is 59.56 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mesa Laboratories (MLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Mesa Laboratories stock appears to be overvalued.
The current stock price of $124.33 is trading 17% above its estimated GF Value™ of $106.26.
GuruFocus considers Mesa Laboratories to be Modestly Overvalued.
Key valuation signals for MLAB:
Days Sales Outstanding: 59.56 (near median its 10-year median of 61.29)
GF Value™: $106.26 vs. price of $124.33 (17% above fair value)
Industry Position: 18.8% below the Hardware median (#794 of 2464)
No single metric tells the full story. See the MLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
75GF Score
Get the complete analysis for MLAB
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLAB has been successfully added to your 
